Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal barrier tight junction proteins are multi-protein complexes that seal the spaces between adjacent epithelial cells of the gut, thereby regulating passage of ions, water, nutrients, and macromolecules via the paracellular route. Key transmembrane protein constituents include occludin, claudins, and junctional adhesion molecules (JAMs), all of which are anchored to the cytoskeleton through intracellular scaffolding proteins like zonula occludens (ZO) family (ZO-1, ZO-2, ZO-3). The dynamic architecture of tight junctions enables the intestinal barrier to respond rapidly to physiological and pathological stimuli, including inflammatory cytokines (e.g., TNF-α, IFN-γ), bacterial toxins, and dietary components. Dysfunction or disruption of tight junctions underlies a wide array of gut-related (e.g., IBD, celiac disease) and systemic (e.g., infection, autoimmunity) diseases, making individual tight junction proteins attractive targets for therapies aimed at restoring barrier integrity. The complexity of tight junction regulation, including intricate signaling pathways, cytoskeletal rearrangement, and crosstalk with immune mediators, presents both opportunities and challenges for drug development.
Inhibition of paracellular permeability (tightening barrier function); Restoration or stabilization of TJ protein expression and localization; Modulation of cytoskeletal interactions or post-translational signaling (preventing TJ protein disassembly); Blocking pro-inflammatory cytokine-induced disruption
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal barrier tight junction protein (TJ protein).